Aimfinity Investment Corp I Enters Into SPAC Merger Agreement With Taiwanese Smart Medical Device Developer Docter Inc
Aimfinity Investment Corp I Enters Into SPAC Merger Agreement With Taiwanese Smart Medical Device Developer Docter Inc
Aimfinity Investment Corp. I ("Aimfinity") (NASDAQ:AIMAU), a Cayman Islands incorporated special purpose acquisition company listed on the Nasdaq Global Market, and Docter Inc. ("Docter"), a Taiwanese non-invasive blood glucose watch developer, today announced that they have entered a definitive merger agreement (the "Merger Agreement") pursuant to which a newly established subsidiary of Aimfinity will become a publicly listed company combining Aimfinity and Docter (the "Combined Company") upon the closing of the transaction contemplated therein (the "Proposed Transaction"). Upon closing, the Combined Company expects to list its ordinary shares on Nasdaq.
在納斯達克全球市場上市的開曼群島註冊特殊目的收購公司Aimfinity Investment Corp.I(“Ainfinity”)(納斯達克股票代碼：AIMAU)和臺灣非侵入性血糖手錶開發商Docter Inc.(“Docter”)今天宣佈，雙方已達成最終合併協定(“合併協定”)，根據該協定，Aimfinity的一家新成立的子公司將於其內擬進行的交易(“建議交易”)完成後成為一家由Aimfinity和Docter合併的上市公司(“合併公司”)。完成交易後，合併後的公司預計將其普通股在納斯達克上市。